Literature DB >> 12797487

Prognostic features of residual pleural thickening in parapneumonic pleural effusions.

D Jiménez Castro1, G Díaz, E Pérez-Rodríguez, R W Light.   

Abstract

The objective of the study was the identification of predictive factors for the development of residual pleural thickening (RPT) in patients with parapneumonic effusion. The design of the prospective study involved investigating patients with parapneumonic pleural effusions diagnosed between March 1991 and December 2000 in the respiratory department of Hospital Ramón y Cajal (Madrid, Spain) which is a 1,500 tertiary-care hospital. The clinical and radiological characteristics and measurements of microbiological and biochemical variables in the pleural fluid taken from the patients were studied. RPT was defined in a posteroanterior chest radiograph as pleural thickening of > or = 10 mm measured at the lateral chest wall at the level of an imaginary line, tangent to the diaphragmatic dome. A total of 48 of the 348 patients studied (13.79%) were found to have RPT. Among the factors studied, only presence of pus in the pleural space, Fine classes IV and V, temperature > or = 38 degrees C and delayed resolution of pleural effusions after diagnosis (> 15 days) were independently associated with the risk of RPT. This study showed that significant residual pleural thickening was not a common complication of parapneumonic pleural effusions. There are certain risk factors for the development of residual pleural thickening. However, this complication was not associated with long-term functional repercussions in the series of patients involved in this study.

Entities:  

Mesh:

Year:  2003        PMID: 12797487     DOI: 10.1183/09031936.03.00099502

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  4 in total

1.  A not so simple effusion.

Authors:  Avinash Aujayeb; Sylvia Worthy; Simon Doe
Journal:  Respir Med Case Rep       Date:  2012-03-19

2.  VEGF correlates with inflammation and fibrosis in tuberculous pleural effusion.

Authors:  Mauo-Ying Bien; Ming-Ping Wu; Wei-Lin Chen; Chi-Li Chung
Journal:  ScientificWorldJournal       Date:  2015-03-26

3.  Clinical importance of angiogenic cytokines, fibrinolytic activity and effusion size in parapneumonic effusions.

Authors:  Chi-Li Chung; Shih-Hsin Hsiao; George Hsiao; Joen-Rong Sheu; Wei-Lin Chen; Shi-Chuan Chang
Journal:  PLoS One       Date:  2013-01-07       Impact factor: 3.240

4.  Two vs. three weeks of treatment with amoxicillin-clavulanate for stabilized community-acquired complicated parapneumonic effusions. A preliminary non-inferiority, double-blind, randomized, controlled trial.

Authors:  José M Porcel; Lucia Ferreiro; Laura Rumi; Esther Espino-Paisán; Carmen Civit; Marina Pardina; Juan Antonio Schoenenberger-Arnaiz; Luis Valdés; Silvia Bielsa
Journal:  Pleura Peritoneum       Date:  2020-02-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.